-
People who opt for nonsmoking rooms in hotels with a partial smoking ban are not fully protected from harmful exposure to so-called "thirdhand" smoke, according to a new study.More >> People who opt for nonsmoking rooms in hotels with a partial smoking ban are not fully protected from harmful exposure to so-called "thirdhand" smoke, according to a new study.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> Scientists report that they were able to improve the math-calculation skills of college students by buzzing their brains with doses of random high-frequency noise.More >> Scientists report that they were able to improve the math-calculation skills of college students by buzzing their brains with doses of random high-frequency noise.More >> As many as one in five American children under the age of 17 has a diagnosable mental disorder in a given year, according to a new federal report.More >> As many as one in five American children under the age of 17 has a diagnosable mental disorder in a given year, according to a new federal report.More >> Eye experts warn that the adhesives used to apply eyelash extensions can cause allergies and infections.More >> Eye experts warn that the adhesives used to apply eyelash extensions can cause allergies and infections.More >> New labeling laws for sunscreen will help American consumers choose the product that provides the best sun protection, experts say.More >> New labeling laws for sunscreen will help American consumers choose the product that provides the best sun protection, experts say.More >> There are few things more inviting than a cool, clear pool on a hot summer day. But a new federal report will have you thinking twice before dipping a toe in the water.More >> There are few things more inviting than a cool, clear pool on a hot summer day. But a new federal report will have you thinking twice before dipping a toe in the water.More >> Drop by for a visit or share the drive -- but please, no smoking.More >> Drop by for a visit or share the drive -- but please, no smoking.More >> People who follow the ancient practice of yoga may be getting an added health boost, with a new study suggesting it can fight high blood pressure -- also known as hypertension.More >> People who follow the ancient practice of yoga may be getting an added health boost, with a new study suggesting it can fight high blood pressure -- also known as hypertension.More >> Men who are physically fit in middle age have a lower risk of developing and dying from certain cancers, new research indicates.More >> Men who are physically fit in middle age have a lower risk of developing and dying from certain cancers, new research indicates.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Oncothyreon Inc.
SEATTLE, WA, March 7, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today
announced that it will conduct a conference call on Thursday, March 14,
2013 at 8:30 a.m. Eastern Time to discuss its financial results and
provide a review of its pipeline of products in development.
To participate in the call by telephone, please dial (877) 280-7291
(United States) or (707) 287-9361 (International). In addition, the
call will be webcast live and can be accessed on the "Events" page of
the "News & Events" section of Oncothyreon's website at www.oncothyreon.com. An archive of the webcast will be available after completion of the
discussion and will be posted on the Oncothyreon website.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
©2012 PR Newswire. All Rights Reserved.
All content © Copyright 2000 - 2013 WorldNow and KTEN. All Rights Reserved.
